ProfileGDS5678 / 1438634_x_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 99% 99% 98% 98% 98% 98% 98% 99% 98% 99% 99% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.594998
GSM967853U87-EV human glioblastoma xenograft - Control 210.60598
GSM967854U87-EV human glioblastoma xenograft - Control 310.797199
GSM967855U87-EV human glioblastoma xenograft - Control 410.969899
GSM967856U87-EV human glioblastoma xenograft - Control 510.570898
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.203598
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.42198
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.597698
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.463798
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.791599
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.587898
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.782799
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.679699
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.527598